Dendritic Cell Vaccine (IRST)

N/A

Report date: 2024/11/28 11:45:44

Base Information

Drug NameDendritic Cell Vaccine (IRST)

Drug Alias NameDC-VACCINE_IRSTIRCCSDendritic Cell (DC) Vaccine (IRST)

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesIstituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST SRL

China Registration ClassN/A

Develop Information

Active CompaniesIstituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST SRL

Inactive CompaniesN/A

Active IndicationsColorectal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A